News Releases

September 22, 2018

Multiple myeloma (MM) is an incurable cancer of the bone marrow. It is the third-most-frequent blood cancer in the US, after lymphoma and leukemia. Several new therapies have recently been approved by the United States Food and Drug Administration (FDA) for treatment of MM, including daratumumab...

September 17, 2018

Patients with drug-resistant epilepsy (DRE) utilize more health care resources and face higher costs than patients who can control their condition with anti-epileptic drugs (AEDs). Despite the long-term proven effectiveness of vagus nerve stimulation (VNS), the treatment is currently...

August 20, 2018

Qualitative data on patients’ experiences and perspectives typically go uncollected in clinical trial settings. Yet patients’ treatment experiences offer complementary insights and context on topics such as disease management, treatment gaps, and previous treatments outside of those gathered in...

July 31, 2018

Often, drug manufacturers are faced with limited study data when developing therapies for rare diseases. To identify challenges in creating economic models, researchers at RTI Health Solutions coauthored a study that reviewed health technology assessment submissions for rare disease treatments...

July 20, 2018

Research on the impact of diabetes on quality of life often focuses on understanding the effect of specific interventions.

July 18, 2018

The PSA test is used to screen men for prostate cancer, however there is controversy around its poor sensitivity and specificity. It can lead to unnecessary biopsies and the overtreatment of low-grade cancers.

July 17, 2018

Communication of Pre-approval Information by Drug and Device Manufacturers to Payers in the US

June 28, 2018

It’s no longer business as usual. We are entering a new era of capturing patients’ voice in cancer drug development. It is critical to remain abreast of trends in the regulatory environment. Ari Gnanasakthy shares takeaways from FDA/ASCO workshop.

June 25, 2018

This new book serves as an essential reference for pharmacovigilance scientists and pharmacoepidemiologists searching for the appropriate study design to answer safety research questions in studies required by regulators. Two RTI Health Solutions (RTI-HS) researchers are contributors. 

June 22, 2018

Biopharmaceutical Innovation Has Significant Impact, According to Physicians Surveyed. A recent survey of U.S. physicians provides insight on their perceptions regarding the impact of medical innovation on outcome

June 12, 2018

Soft tissue sarcoma (STS) is a rare group of malignant tumors comprising more than 50 histologic subtypes that are derived from connective tissues and other cells of mesenchymal origin. They account for approximately 1% of all incident malignancies.

May 22, 2018

Understanding What Matters Most to Alzheimer's patients and their caregivers to help inform the drug development process.
The Alzheimer’s Disease Patient and Caregiver Engagement (AD PACE) initiative is a first-of-its-kind collaboration among pharmaceutical companies, advocacy...

May 18, 2018

Research team members each have their own areas of expertise, which may not include experience with raw data.  They all need tools they can understand to help them assess the data. 

May 9, 2018

A small subgroup who have been on HIV treatment a long time have developed resistance to most currently available treatments

May 9, 2018

Guidelines for economic systematic reviews are sparse, and those available mainly focus on economic evaluations or health state utility values. 

May 9, 2018

Most patients reported that the benefits of their therapy met or exceeded their expectations

May 8, 2018

Relationship Between Compliance & Blindness Prevention in Diabetic Retinopathy Screening

May 8, 2018

CDFs and PDFs: Comparing Visual Methods Supporting Responder Thresholds in Clinical Trials

May 8, 2018

Research: Programmed Cell Death LIGAND-1 Testing Among Patients with Metastatic Non-Small Cell Lung Cancer

May 8, 2018

Research: Prescription Opioid Use Among Children and Adolescents with Asthma

May 7, 2018

Should affordability of new drug and medical technology be managed within current budgets, should we raise premiums or taxes, or should payors rely on price negotiations?

May 1, 2018

I am honored to have co-authored a chapter titled “Integration of patient-reported outcomes in industry-sponsored clinical trials” in the second edition of Oncology Clinical Trials.

April 23, 2018

In this study, our objective was to examine treatment patterns, possible statin intolerance, and incidence of cardiovascular events in patients with high cardiovascular risk - particularly ASCVD and type 2 diabetes.

April 17, 2018

In a follow-up of the Salford Lung Study (SLS) in COPD, RTI-HS researchers evaluated outcomes not traditionally examined in clinical trials and gained insight into patient experiences.